Apoptosis inhibitor 5 increases metastasis via Erk-mediated MMP expression |
Song, Kwon-Ho
(Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University)
Kim, Seok-Ho (Immunotherapy Research Center, Korea Research Institute of Bioscience & Biothechnology (KRIBB)) Noh, Kyung Hee (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) Bae, Hyun Cheol (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) Kim, Jin Hee (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) Lee, Hyo-Jung (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) Song, Jinhoi (Immunotherapy Research Center, Korea Research Institute of Bioscience & Biothechnology (KRIBB)) Kang, Tae Heung (Department of Immunology, School of Medicine, Konkuk University) Kim, Dong-Wan (Department of Internal Medicine, Seoul National University College of Medicine) Oh, Se-Jin (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) Jeon, Ju-Hong (Department of Physiology, Seoul National University, College of Medicine) Kim, Tae Woo (Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University) |
1 | Han BG, Kim KH, Lee SJ et al (2012) Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules. J Biol Chem 287, 10727-10737 DOI ScienceOn |
2 | Rigou P, Piddubnyak V, Faye A et al (2009) The antiapoptotic protein AAC-11 interacts with and regulates Acinusmediated DNA fragmentation. EMBO J 28, 1576-1588 DOI ScienceOn |
3 | Simon C, Simon M, Vucelic G et al (2001) The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res 271, 344-355 DOI ScienceOn |
4 | Wang Y and Prywes R (2000) Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 19, 1379-1385 DOI |
5 | Gianfrancesco F, Esposito T, Ciccodicola A et al (1999) Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene. Cytogenet Cell Genet 84, 164-166 DOI ScienceOn |
6 | Morris L, Allen KE and La Thangue NB (2000) Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Nat Cell Biol 2, 232-239 DOI ScienceOn |
7 | Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW and Dyson NJ (2006) Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet 2, e196 DOI ScienceOn |
8 | Tewari M, Yu M, Ross B, Dean C, Giordano A and Rubin R (1997) AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res 57, 4063-4069 |
9 | Koci L, Chlebova K, Hyzdalova M et al (2012) Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo. Oncology Lett 3, 913-916 |
10 | Garcia-Jove Navarro M, Basset C, Arcondeguy T et al (2013) Api5 contributes to E2F1 control of the G1/S cell cycle phase transition. PLoS One 8, e71443 DOI |
11 | Ren K, Zhang W, Shi Y and Gong J (2010) Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway. Pathol Oncol Res 16, 229-237 DOI |
12 | Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H and Bugler B (2000) FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol 14, 1709-1724 DOI |
13 | Chung TW, Moon SK, Chang YC et al (2004) Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J 18, 1670-1681 DOI ScienceOn |
14 | Tseng HC, Lee IT, Lin CC et al (2013) IL-1beta promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-kappaB- and AP-1-dependent pathways. PLoS One 8, e57955 DOI |